| Financial Year |
March 31 2023 |
| Monetary Funds |
401,205,341.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
194,798,622.55 |
| Advances to Suppliers |
20,867,557.46 |
| Other Receivables |
26,178,817.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
655,052,247.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,048,845.44 |
| Total Current Assets |
1,372,305,413.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
67,444,230.07 |
| Under-construction Projects |
144,115,666.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
124,833,172.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,859,908.36 |
| Deferred Income Tax Assets |
8,999,327.15 |
| Other Non-Current Assets |
292,060,428.08 |
| Sub-Total of Non-Current Assets |
673,556,381.72 |
| Total Assets |
2,045,861,795.59 |
| Short-Term Loans |
77,579,643.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
260,827,024.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,826,164.82 |
| Taxes Payable |
5,017,554.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
94,717,944.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,363,487.87 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
480,460,709.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
26,468,185.83 |
| Deferred Income Tax Liabilities |
1,745,393.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,021,189.54 |
| Total Liabilities |
512,481,899.00 |
| Paid-In Capital(Or Share Stock) |
342,039,282.00 |
| Capital Surplus |
314,130,137.83 |
| Surplus Reserve |
148,053,017.54 |
| LESS:Treasury Stock |
83,586,918.81 |
| Undistributed Profits |
778,345,607.66 |
| Minority Stockholder's Interest |
30,339,058.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,503,040,837.69 |
| Owner's Equity（Stockholder's Equity） |
1,533,379,896.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,045,861,795.59 |
